The global demand for Ivermectin Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period of 2022 - 2028. Regarding volume, the market was calculated XX Kilo Tons in 2021 and forecast to touch XX Kilo Tons by 2028 with a CAGR of XX% during 2022-2028.
Ivermectin is an antihelmintics drug used to treat parasite infections, including onchocerciasis, helminthiases, head lice, river blindness, strongyloidiasis, trichuriasis, ascariasis, lymphatic filariasis, and scabies. It is also used to prevent and treat heartworm and acariasis in animals. Ivermectin works by paralyzing and killing parasites. It was discovered in 1975 and came into commercial use in 1981. Ivermectin is available as a cream, and a lotion applies to the skin. Recently, ivermectin has been proven to treat SARS-CoV-2. It is also being assessed for its potential for malaria transmission.
Market Dynamics
Epidermal parasitic skin diseases are growing in humans and animals, resulting in a requirement for therapeutics. Poor hygiene is a significant risk factor causing these diseases. Increasing research activities on the exploration of ivermectin potentials are expected to present many market opportunities. The global ivermectin market is projected to witness the massive growth in the coming years owing to its potential to inhibit COVID-19 symptoms. It has been scientifically proven that ivermectin inhibits the replication of SARS-CoV-2. This brings many lucrative opportunities for growth. Companies have launched ivermectin specified for COVID-19, ramping up their production capacities to combat the second and third wave of the COVID-19 pandemic. As a result, the tablet segment is anticipated to grow faster during the forecast period. However, approvals hurdle and the availability of other alternative treatment options are several factors inhibiting the market growth.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of ivermectin. The growth and trends of Ivermectin Industry provide a holistic approach to this study.
Market Segmentation
This section of the ivermectin market report provides detailed data on the segments by analyzing them at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Form
By Application
- Parasite Infection
- COVID-19
- Others
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Ivermectin market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Ivermectin Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the ivermectin market include SAMEX OVERSEAS, MERCK, Zhejiang Hisun Pharmaceutical, LAND, Hero Pharmaceutical, Bajaj Healthcare, Nicholas Piramal India Ltd. (NPIL), Sunpharma, and Glenmark. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.